Condition
DNA Methylation clinical trials and research
As of November 12, 2026, Find a Trial lists 6 DNA Methylation clinical trials that are recruiting, at sites in 4 countries (most in China (2), Japan (2), France (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest DNA Methylation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Methylation markers from saliva to guide lung cancer screening | — | Antwerp, Antwerpen | Recruiting | Jun 8, 2026 |
| Predicting how well chemotherapy will work for esophageal cancer patients | — | Chūō, Yamanashi | Recruiting | Jul 8, 2024 |
| Predicting early tumor recurrence in esophageal cancer patients | — | Nagoya, Aichi-ken and 1 other locations | Recruiting | Jun 26, 2024 |
| Classifying cancer of unknown primary using DNA methylation data | — | Guangzhou, Guangdong | Recruiting | Nov 21, 2023 |
| Saliva DNA methylation test for diagnosing oral cavity squamous cell carcinoma | — | Amiens, Picardie | Recruiting | Mar 30, 2023 |
| Developing a diagnostic model for pancreatic cystic tumors using fluid samples | — | Shanghai, Shanghai Municipality | Recruiting | Feb 21, 2023 |
All recruiting trials (6)
-
Methylation markers from saliva to guide lung cancer screening
This study tests whether DNA methylation patterns in saliva can more accurately identify people who should get a low-dose CT scan for lung cancer screening.
-
Predicting how well chemotherapy will work for esophageal cancer patients
This study is testing if DNA changes in biopsy samples can help doctors predict how well chemotherapy will work for patients with esophageal cancer, so those who might not benefit can avoid unnecessary treatment.
-
Predicting early tumor recurrence in esophageal cancer patients
This study is testing if certain DNA patterns from tissue samples can help predict if esophageal cancer will come back early in patients who have had surgery.
-
Classifying cancer of unknown primary using DNA methylation data
This study is trying to see if a new computer model can help doctors figure out what type of cancer someone has when they don't know where it started, by looking at patterns in DNA from cancer samples.
-
Saliva DNA methylation test for diagnosing oral cavity squamous cell carcinoma
This tests whether a saliva DNA methylation test can detect oral squamous cell carcinoma in adults scheduled for maxillofacial surgery.
-
Developing a diagnostic model for pancreatic cystic tumors using fluid samples
This study is testing if analyzing fluid samples from patients with pancreatic cystic tumors can help doctors tell the difference between harmless and harmful tumors.
Related topics
Quick answers
How many DNA Methylation clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), Japan (2 trials), France (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.